New Oral Capsule Offers Hope for Diabetics Seeking Relief from Injections

New Oral Capsule Offers Hope for Diabetics Seeking Relief from Injections

A team of scientists from RMIT University in Melbourne, Australia, has developed a new type of oral capsule that could allow for pain-free delivery of protein drugs, including insulin.

Protein drugs are difficult to deliver orally, as they quickly degrade in the stomach. The new capsule has a special coating that prevents it from breaking down in the stomach's low pH environment before it dissolves in the small intestine. The insulin is packaged inside a fatty nanomaterial within the capsule to help it cross the intestinal walls. 

The team tested the capsule with both fast-acting and slow-acting insulin in a pre-clinical study (published in the international journal Biomaterials Advances) and found good absorption results for the slow-acting form, about 50% sounder than injection delivery for the same dose of insulin. The capsule also achieved good absorption results for fast-acting insulin, but it lagged markedly in the insulin-taking effect compared with injection delivery, likely making it less practical.

According to Dr. Céline Valéry, a pharmaceutical scientist from RMIT University and co-author of the study, "Numerous research studies employ oral formulations with significantly higher insulin quantities to achieve the same reaction as injection delivery, which is not a cost-efficient approach for administering expensive protein medications, such as insulin."

Adding to their achievement, Co-lead researcher Professor Charlotte Conn said, "Our study shows promising results for using these oral capsules for slow-acting insulin, which diabetics could take along with the fast-acting insulin injections." She further added, "We can also employ this technology to deliver other protein drugs orally, including a new type of oral antibiotic developed by the RMIT team that can bypass resistance to hazardous superbugs. Further, we have also filed an international patent application for our technology."

IJCP Editorial Team

Comprising seasoned professionals and experts from the medical field, the IJCP editorial team is dedicated to delivering timely and accurate content and thriving to provide attention-grabbing information for the readers. What sets them apart are their diverse expertise, spanning academia, research, and clinical practice, and their dedication to upholding the highest standards of quality and integrity. With a wealth of experience and a commitment to excellence, the IJCP editorial team strives to provide valuable perspectives, the latest trends, and in-depth analyses across various medical domains, all in a way that keeps you interested and engaged.

 More FAQs by IJCP Editorial Team


Medtalks is India's fastest growing Healthcare Learning and Patient Education Platform designed and developed to help doctors and other medical professionals to cater educational and training needs and to discover, discuss and learn the latest and best practices across 100+ medical specialties. Also find India Healthcare Latest Health News & Updates on the India Healthcare at Medtalks